Amathus Therapeutics Overview

  • Founded
  • 2018
Founded
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Latest Deal Amount
  • $50K
Latest Deal Amount
  • Investors
  • 3

Amathus Therapeutics General Information

Description

Developer of small-molecule therapeutics intended to enhance mitochondrial function. The company's therapeutics help in the treatment of rare lysosomal-storage disorders such as Parkinson's, enabling doctors to treat neurodegenerative disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Discovery Tools (Healthcare)
Primary Office
  • 700 Main Street North
  • Cambridge, MA 02139
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Amathus Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 14-Nov-2018 $50K Completed Startup
1. Early Stage VC Completed Startup
To view Amathus Therapeutics’s complete valuation and funding history, request access »

Amathus Therapeutics Executive Team (3)

Name Title Board Seat Contact Info
David Weiner MD Chief Executive Officer
Yiannis Ioannou Ph.D Chair, Scientific Advisory Board & Founder
Edward Holson Ph.D Chief Scientific Officer
To view Amathus Therapeutics’s complete executive team members history, request access »

Amathus Therapeutics Board Members (1)

Name Representing Role Since
Yiannis Ioannou Ph.D Amathus Therapeutics Chair, Scientific Advisory Board & Founder 000 0000
To view Amathus Therapeutics’s complete board members history, request access »

Amathus Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
LabCentral University 000 0000 000000 0
Servier Corporation Minority 000 0000 000000 0
Dementia Discovery Fund Venture Capital Minority 000 0000 000000 0
To view Amathus Therapeutics’s complete investors history, request access »